Pharmacokinetics and neurochemical effects of pentazocine and its optical isomers.
D000042:Absorption; D000284:Administration, Oral; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D001679:Biogenic Amines / Q000037:antagonists & inhibitors; D001702:Biopharmaceutics; D001921:Brain / Q000378:metabolism; D002849:Chromatography, Gas; D003864:Depression, Chemical; D005470:Fluorometry; D005965:Glucuronates / Q000096:biosynthesis; D006207:Half-Life; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D007536:Isomerism; D007700:Kinetics; D051379:Mice; D009292:Narcotic Antagonists / Q000494:pharmacology; D010084:Oxidation-Reduction; D010423:Pentazocine / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D012119:Respiration / Q000187:drug effects; D013997:Time Factors
D000700:Analgesics; D001679:Biogenic Amines; D005965:Glucuronates; D009292:Narcotic Antagonists; D010423:Pentazocine